boustead singapore

Post-acquisition, UroMedTech will continue to operate under its existing brand

2026-07-03T12:49:22.000Z

Move is expected to have positive material impact on profitability and EPS in the financial year ending Mar 31, 2027

2026-06-16T12:27:50.000Z

Full-year earnings are up 145%; the board proposes a final ordinary dividend of S$0.04 a share

2026-05-25T16:24:13.000Z

The real estate investment trust may fully purchase the asset after it gets a temporary occupation permit

2026-05-22T16:16:51.000Z

This brings the real estate solutions division’s order backlog to S$837 million

2026-04-26T11:33:35.000Z

It is the first 2026 mainboard listing, and follows a strong offering pipeline in 2025

2026-03-12T06:10:11.000Z

The counter is expected to begin trading at 2 pm on Mar 12

2026-03-11T13:21:35.000Z

Following the offering, the trust will have a total market capitalisation of S$1.95 billion

2026-03-05T10:37:28.000Z

The initial portfolio of UI Boustead Reit will have 23 properties valued at about S$1.9 billion

2026-02-10T00:32:12.000Z

This allows the company to better manage its real estate and fund management business in one of Asean’s fastest growing economy

2026-01-13T02:39:22.000Z